chr14-23394178-C-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_002471.4(MYH6):c.2575G>T(p.Gly859Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,614,094 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G859R) has been classified as Uncertain significance.
Frequency
Consequence
NM_002471.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 14Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
- Keppen-Lubinsky syndromeInheritance: AD Classification: MODERATE Submitted by: Illumina
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- atrial septal defect 3Inheritance: AD Classification: LIMITED Submitted by: G2P
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYH6 | NM_002471.4 | c.2575G>T | p.Gly859Trp | missense_variant | Exon 21 of 39 | ENST00000405093.9 | NP_002462.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152200Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000517 AC: 13AN: 251484 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1461894Hom.: 0 Cov.: 33 AF XY: 0.0000371 AC XY: 27AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74358 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:4
- -
- -
- -
MYH6: PS4:Supporting, BP4 -
Hypertrophic cardiomyopathy 14 Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 859 of the MYH6 protein (p.Gly859Trp). This variant is present in population databases (rs369274077, gnomAD 0.01%). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 30847666). ClinVar contains an entry for this variant (Variation ID: 191718). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYH6 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiomyopathy Uncertain:1
- -
Dilated cardiomyopathy 1EE;C2750467:Hypertrophic cardiomyopathy 14;C3279790:Atrial septal defect 3;C3279791:Sick sinus syndrome 3, susceptibility to;C3495498:Hypertrophic cardiomyopathy 1 Uncertain:1
- -
Heart disease Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.G859W variant (also known as c.2575G>T), located in coding exon 19 of the MYH6 gene, results from a G to T substitution at nucleotide position 2575. The glycine at codon 859 is replaced by tryptophan, an amino acid with highly dissimilar properties. This variant has been detected in individuals tested for hypertrophic and dilated cardiomyopathy and has co-occurred with a variant in the SOS1 gene in a sudden death case (van Lint FHM et al. Neth Heart J. 2019 Jun;27(6):304-309; Salfati EL et al. Genome Med. 2019 12;11(1):83). This alteration has also been reported as a secondary cardiac variant in an exome cohort (Ng D et al. Circ Cardiovasc Genet, 2013 Aug;6:337-46). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not specified Benign:1
Variant summary: MYH6 c.2575G>T (p.Gly859Trp) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 4.2e-05 in 1607098 control chromosomes. The observed variant frequency is approximately 1.7-fold of the estimated maximal expected allele frequency for a pathogenic variant in MYH6 causing Cardiomyopathy phenotype (2.5e-05). The variant, c.2575G>T, has been observed in individuals affected with various forms of cardiomyopathy, including hypertrophic-, dilated-, and arrhythmogenic (right ventricular) cardiomyopathy (e.g. van Lint_2019, Salfati_2019, Goli_2021), however in none of these cases was supportive evidence for causality provided. These reports do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30847666, 31847883, 33874732). ClinVar contains an entry for this variant (Variation ID: 191718). Based on the evidence outlined above, the variant was classified as likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at